MRI of transgene expression: correlation to therapeutic gene expression.

[1]  Thomas L. Chenevert,et al.  Molecular Imaging of Gene Expression and Efficacy following Adenoviral-Mediated Brain Tumor Gene Therapy , 2002 .

[2]  Daniel E. Hall,et al.  Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. , 2002, Molecular imaging.

[3]  E. Tyminski,et al.  An infectious transfer and expression system for genomic DNA loci in human and mouse cells , 2001, Nature Biotechnology.

[4]  K Wienhard,et al.  Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas , 2001, The Lancet.

[5]  N. Satyamurthy,et al.  Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors , 2001, Gene Therapy.

[6]  X. Breakefield,et al.  Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  R Weissleder,et al.  In vivo imaging of gene expression:. , 2001, Academic radiology.

[8]  R Weissleder,et al.  Improvement of MRI probes to allow efficient detection of gene expression. , 2000, Bioconjugate chemistry.

[9]  S. Ylä-Herttuala,et al.  Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses. , 2000, Human gene therapy.

[10]  R Weissleder,et al.  New approaches for imaging in gene therapy. , 2000, European journal of radiology.

[11]  E. A. Chiocca,et al.  Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. , 2000, Journal of neurosurgery.

[12]  R. Martuza,et al.  Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial , 2000, Gene Therapy.

[13]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[14]  S. Larson,et al.  Imaging transgene expression with radionuclide imaging technologies. , 2000, Neoplasia.

[15]  R. Blasberg,et al.  Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. , 1999, Cancer research.

[16]  S. Larson,et al.  A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. , 1999, Neoplasia.

[17]  R. Chung,et al.  B-myb Promoter Retargeting of Herpes Simplex Virus γ34.5 Gene-Mediated Virulence toward Tumor and Cycling Cells , 1999, Journal of Virology.

[18]  R G Blasberg,et al.  Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Louis,et al.  Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses , 1999, Nature Medicine.

[20]  R. Jain,et al.  Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies , 1999, British Journal of Cancer.

[21]  E. Chiocca,et al.  Neurogenetic surgery: current limitations and the promise of gene- and virus-based therapies. , 1999, Clinical neurosurgery.

[22]  C. Fraefel,et al.  Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. , 1998, Human gene therapy.

[23]  D. Klatzmann,et al.  A phase I/II dose-escalation study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for metastatic melanoma. Study Group on Gene Therapy of Metastatic Melanoma. , 1998, Human gene therapy.

[24]  M. Dunlop,et al.  Gene therapy for colon cancer. , 1998, Hematology/oncology clinics of North America.

[25]  T. McGraw,et al.  The Transferrin Receptor Cytoplasmic Domain Determines Its Rate of Transport through the Biosynthetic Pathway and Its Susceptibility to Cleavage Early in the Pathway* , 1998, The Journal of Biological Chemistry.

[26]  R Weissleder,et al.  Measuring transferrin receptor gene expression by NMR imaging. , 1998, Biochimica et biophysica acta.

[27]  K. Dobberstein,et al.  A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma. , 1998, Advances in experimental medicine and biology.

[28]  I. Runnebaum.  Basics of cancer gene therapy. , 1997, Anticancer research.

[29]  O. Bogler,et al.  A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. , 1996, Cancer research.

[30]  W. Cavenee,et al.  A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  X. Breakefield,et al.  Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene. , 1994, Human gene therapy.

[32]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[33]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[34]  X. Breakefield,et al.  A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. , 1988, Science.

[35]  G. Kreibich,et al.  Signals for the incorporation and orientation of cytochrome P450 in the endoplasmic reticulum membrane , 1988, The Journal of cell biology.

[36]  G. Andersson,et al.  The transferrin receptor in hepatocyte nodules: binding properties, subcellular distribution and endocytosis. , 1986, Carcinogenesis.

[37]  J. Kushner,et al.  Internalization and subcellular localization of transferrin and transferrin receptors in HeLa cells. , 1983, The Journal of biological chemistry.